Real-time enrollment status for this uterine cancer clinical trial
Current Status
Completed
Checked: April 17, 2026 at 3:43 AM UTC
| NCT Number | NCT04814108 |
| Recruiting Status | Completed |
| Condition | Uterine Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 76 participants |
| Active Locations | 37 sites in the US |
| Sponsor | K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc |
| Last Updated on CT.gov | March 18, 2026 (Mar 18, 2026) |
As of April 17, 2026: Clinical trial NCT04814108 is currently completed participants. This clinical trial study for uterine cancer is not currently accepting new participants at 37 locations across the United States. The study is sponsored by K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT04814108 is currently completed. The study may resume recruiting in the future.
This trial is recruiting at 37 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04814108 was last updated Mar 18, 2026 (March 18, 2026). HelloStudys verifies this status automatically.